Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001078782-16-002295
Filing Date
2016-02-09
Accepted
2016-02-09 15:56:47
Documents
1
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4/A  
1 PRIMARY DOCUMENT primary_doc.xml 4/A 16502
  Complete submission text file 0001078782-16-002295.txt   17969
Mailing Address 1 SCOTTS RD #24-05 SHAW CENTRE SINGAPORE U0 228208
Business Address 1 SCOTTS RD #24-05 SHAW CENTRE SINGAPORE U0 228208 1 (646) 650-1351
VOLITIONRX LTD (Issuer) CIK: 0000093314 (see all company filings)

EIN.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 49 A/B HANOVERGATE MANSIONS PARK RD LONDON X0 NW1 4SN
Business Address
Reynolds Cameron John (Reporting) CIK: 0001340610 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36833 | Film No.: 161399620